SHC
Sotera Health Company Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$11.750
Kõrge
$11.750
Madal
$11.750
Maht
0.46M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
Sotera Health 'Is Uniquely Insulated From Potential Tariff Policy,' Goldman Sachs Says
Goldman Sachs upgrades Sotera Health to Buy, citing tariff immunity, legal clarity, and exposure to Medtech innovation for future growth.
Goldman Sachs Upgrades Sotera Health to Buy, Raises Price Target to $17
Goldman Sachs analyst Matthew Sykes upgrades Sotera Health from Neutral to Buy and raises the price target from $14 to $17.
Sotera Health Reports First-Quarter 2025 Results
Q1 2025 net revenues increased 2.6% to $255 million, compared to Q1 2024, or 4.4% on a constant currency basisQ1 2025 net loss of $13 million or $0.05 per diluted share, compared to net income of $6 million or $0.02 per
Piper Sandler Maintains Neutral on Sotera Health, Lowers Price Target to $13
Piper Sandler analyst Jason Bednar maintains Sotera Health with a Neutral and lowers the price target from $15 to $13.
Sotera Health Announces First-Quarter 2025 Earnings Release Date
CLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.